HOME
ABOUT
TEAM
PORTFOLIO
Information Technology
Life Sciences
Energy Technology
NEWS
Investments in Exela Pharma Sciences to secure & support U.S based drug supply & manufacturing
Solaria Corporation Unveils World Class Executive Team
Altimmune Completes First Development Milestone Toward A Single-Dose Intranasal COVID-19 Vaccine
CONTACT
Copyright ©
Presidio Partners
Design by Sterling Communications
Ardelyx Receives $25 Million Milestone From AstraZeneca For Commencement Of Phase 2b Clinical Trial Of Tenapanor
SHARE THE NEWS:
